(Senior) Medical Science Liaison- Central Midwest
TempusFull Time
Senior (5 to 8 years), Expert & Leadership (9+ years)
United States
Candidates must have a strong scientific background, preferably with an advanced degree (MD, PharmD, PhD) in a relevant scientific or clinical discipline. A minimum of 5 years of experience as a Medical Science Liaison (MSL) or in a similar role within the pharmaceutical or biotechnology industry is required. Demonstrated experience in oncology, particularly with radiopharmaceuticals or targeted therapies, is essential. Proven ability to establish and maintain relationships with Key Opinion Leaders (KOLs) and Healthcare Providers (HCPs) is necessary. Extensive travel within the assigned territory is expected.
The Senior MSL will serve as the primary medical resource for the external healthcare community, facilitating peer-to-peer scientific exchange and translating complex science into patient care insights. Responsibilities include identifying medical needs related to disease and products within a defined geography, developing and maintaining relationships with KOLs and HCPs, and ensuring patients have access to clinical trial compounds and marketed products. The role involves gathering key medical insights from KOLs/HCPs, acting as a clinical and scientific advisor, and collaborating with internal teams (clinical development, clinical operations, medical affairs) to execute the therapeutic product development process. Additionally, the Senior MSL will contribute to launch and commercialization strategies, facilitate scientific exchange, and gather external insights to inform the company's understanding of the therapeutic landscape. This includes attending conferences, presenting scientific product information, and representing the company credibly within the oncology community.
Develops and delivers biopharmaceutical medicines
Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.